A case-control study conducted on 57 IM-resistant CML patients and 38 responders found significantly higher levels of HOXA4 hypermethylation in IM-resistant patients [46]. The gene discussed is HOXA4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.